Fetuin-A as a predicator of sarcopenic left ventricular dysfunction

Wei Ting Chang, Wei Chuan Tsai, Chih Hsing Wu, Yen Wei Lee, Yun Lin Tai, Yi Heng Li, Liang Miin Tsai, Jyh Hong Chen, Ping Yen Liu

研究成果: Article同行評審

9 引文 斯高帕斯(Scopus)


Sarcopenia is an aging condition involving low muscle mass and function. Fetuin-A (FetA) appears to be a factor for body composition remodeling. We hypothesized that age increases FetA levels and deteriorates the myocardial function by affecting diastolic function, especially in people with sarcopenia. We enrolled 541 asymptomatic elderly (≥65 years) patients. Compared with non-sarcopenic population, FetA levels were significantly elevated in the ninety-two (17%) patients (79 ± 6 years; male: 34.7%) diagnosed with sarcopenia (621.1 ± 140.7 vs. 697.3 ± 179.6 μg/ml, < 0.001). Sarcopenic left ventricular dysfunction (S-LVD) was defined by the coexistence of sarcopenia and systolic impairment (LVEF < 50%) and 23 (4.3%) of them met the criteria. Patients with S-LVD showed relatively reduced systolic heart function, higher end-diastolic pressure and a higher FetA level (all p < 0.001) than did those with sarcopenia but without LV dysfunction (S-NLVD). Conversely, in the group without sarcopenia, FetA levels were similar regardless of systolic function. Multivariable logistic regression showed that older age, impaired diastolic function, and higher FetA levels were significantly associated with S-LVD. In conclusion, we found that FetA was significantly higher in elderly patients with sarcopenia, which was associated with impaired diastolic and systolic functions.

期刊Scientific reports
出版狀態Published - 2015 7月 10

All Science Journal Classification (ASJC) codes

  • 多學科


深入研究「Fetuin-A as a predicator of sarcopenic left ventricular dysfunction」主題。共同形成了獨特的指紋。